PBS updates

Lonsurf 15/6.14 (Trifluridine + tipiracil)

trifluridine 15 mg + tipiracil 6.14 mg tablet, 20 · ORAL · PBS code 12056M

STREAMLINED

What it costs

AU$707.14 PBS-determined price per 60 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

  • • First listed on the PBS: 2020-06-01.
  • • Repeats: 2.
  • • PBS program: GE.
Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Metastatic (Stage IV) adenocarcinoma of the stomach or gastro-oesophageal junction


Initial treatment


Patient must have a WHO performance status of 1 or less; AND

Patient must have previously received at least two prior lines of chemotherapy that included a fluoropyrimidine, a platinum and either a taxane or irinotecan; AND

The treatment must be the sole PBS-subsidised therapy for this condition.

The patient's WHO performance status and body weight must be documented in the patient's medical records at the time the treatment is initiated.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Metastatic (Stage IV) adenocarcinoma of the stomach or gastro-oesophageal junction


Continuing treatment


Patient must have previously received PBS-subsidised treatment with this drug for this condition; AND

Patient must not develop progressive disease whilst receiving PBS-subsidised treatment with this drug for this condition; AND

The treatment must be the sole PBS-subsidised therapy for this condition.

Sponsor: Servier Laboratories (Aust.) Pty. Ltd. ABN 54 004 838 500

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.